Posts

Showing posts matching the search for Guggenheim

Guggenheim Raises BeOne Medicines Stock Price Target on Revenue Beat

Image
Guggenheim Raises BeOne Medicines Stock Price Target on Revenue Beat THE MONEYWISE JOURNAL  ·  finance  ·  Thursday, August 06, 2026 The investment firm now predicts a higher stock price for BeOne Medicines, reflecting the company's recent financial performance. By MoneyWise Guide Guggenheim has increased its stock price target for BeOne Medicines, following the company's revenue beat. The investment firm now predicts a higher stock price for BeOne Medicines, reflecting the company's recent financial performance. Key Takeaways Key Takeaways Guggenheim has raised its stock price target for BeOne Medicines. The investment firm's decision follows the company's revenue beat. BeOne Medicines' financial performance has led to the increased stock price target. Quick Facts Metric Value Why it matters Stock Price Target Increased by Guggenheim Reflects BeOne Medicin...

Guggenheim Ties Weigh on Acrisure Debt, Dragging High‑Yield Credit Markets

Image
Guggenheim Ties Weigh on Acrisure Debt, Dragging High‑Yield Credit Markets THE MONEYWISE JOURNAL  ·  finance  ·  Sunday, August 30, 2026 The announcement came amid a decline in some of the company’s bonds and loans, though those securities remained above the thresho… By MoneyWise Guide Acrisure, a hybrid fintech and insurance brokerage, announced in late May 2026 that it would cut 11% of its workforce—approximately 2,250 employees—as part of a sweeping overhaul to modernize operations. The announcement came amid a decline in some of the company’s bonds and loans, though those securities remained above the thresholds typically considered distressed. Key Takeaways Acrisure announced an 11% workforce reduction, equating to about 2,250 employees. The cut was announced in late May 2026 as part of a modernization effort. Some of Acrisure’s bonds and loans have fallen in value, yet they remain above distressed lev...